NRD.E1, an innovative non‐opioid therapy for painful diabetic peripheral neuropathy—A randomized proof of concept study

BACKGROUND: Painful diabetic peripheral neuropathy (PDPN) affects up to 26% of patients with diabetes mellitus, with major impacts on their general health and well‐being. Most available drugs fail to deliver acceptable pain reduction in the majority of patients and are often poorly tolerated. NRD.E1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiecke, Eva, Rainisio, Maurizio, Eisenberg, Elon, Wainstein, Julio, Kaplan, Eli, Silverberg, Michal, Hochman, Liat, Mangialaio, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540529/
https://www.ncbi.nlm.nih.gov/pubmed/35671086
http://dx.doi.org/10.1002/ejp.1989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540529/
https://www.ncbi.nlm.nih.gov/pubmed/35671086
http://dx.doi.org/10.1002/ejp.1989

Ejemplares similares